Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs
Open Access
- 1 March 2021
- Vol. 10 (3), 521
- https://doi.org/10.3390/cells10030521
Abstract
The Notch family includes evolutionary conserved genes that encode for single-pass transmembrane receptors involved in stem cell maintenance, development and cell fate determination of many cell lineages. Upon activation by different ligands, and depending on the cell type, Notch signaling plays pleomorphic roles in hepatocellular carcinoma (HCC) affecting neoplastic growth, invasion capability and stem like properties. A specific knowledge of the deregulated expression of each Notch receptor and ligand, coupled with resultant phenotypic changes, is still lacking in HCC. Therefore, while interfering with Notch signaling might represent a promising therapeutic approach, the complexity of Notch/ligands interactions and the variable consequences of their modulations raises concerns when performed in undefined molecular background. The gamma-secretase inhibitors (GSIs), representing the most utilized approach for Notch inhibition in clinical trials, are characterized by important adverse effects due to the non-specific nature of GSIs themselves and to the lack of molecular criteria guiding patient selection. In this review, we briefly summarize the mechanisms involved in Notch pathway activation in HCC supporting the development of alternatives to the γ-secretase pan-inhibitor for HCC therapy.This publication has 154 references indexed in Scilit:
- Notch-driven carcinogenesis: The merging of hepatocellular cancer and cholangiocarcinoma into a common molecular liver cancer subtypeJournal of Hepatology, 2013
- The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinomaBMC Cancer, 2013
- LincRNA-p21 Suppresses Target mRNA TranslationMolecular Cell, 2012
- IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageJournal of Hepatology, 2010
- cis-Inhibition of Notch by Endogenous Delta Biases the Outcome of Lateral InhibitionCurrent Biology, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3Journal of Hepatology, 2009
- Factors determining antibody distribution in tumorsTrends in Pharmacological Sciences, 2008
- Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interferenceJournal of Hepatology, 2007
- Nucleotide sequence from the neurogenic locus Notch implies a gene product that shares homology with proteins containing EGF-like repeatsCell, 1985